Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
12/17/2013 | US8609678 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
12/17/2013 | US8609674 Potassium channel modulators |
12/17/2013 | US8609673 Vandetanib derivatives |
12/17/2013 | US8609672 Piperazinylpyrimidine analogues as protein kinase inhibitors |
12/17/2013 | US8609667 E-type phenyl acrylic ester compounds containing substituted anilino pyrimidine group and uses thereof |
12/17/2013 | US8609592 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
12/12/2013 | WO2013184570A2 Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds |
12/12/2013 | WO2013184202A1 Fbxo3 inhibitors |
12/12/2013 | WO2013182993A1 Method for preparing nitrogen compounds |
12/12/2013 | WO2013182046A1 Organic electronic material and organic electroluminescent device |
12/12/2013 | WO2013181828A1 Preparation method of rosuvastatin calcium and intermediates thereof |
12/12/2013 | WO2011080494A3 Cosmetic composition, cosmetic treatment method, kit, and compound |
12/12/2013 | US20130331570 Aryl urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
12/12/2013 | US20130331407 Inhibitors of protein kinases |
12/12/2013 | US20130331392 Cycloalkyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
12/12/2013 | US20130331391 Viral polymerase inhibitors |
12/12/2013 | US20130331370 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
12/12/2013 | CA2875305A1 Fbxo3 inhibitors |
12/11/2013 | EP2672540A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same |
12/11/2013 | EP2670736A1 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof |
12/11/2013 | CN103443085A Quinazolinediones and their use |
12/11/2013 | CN103442568A Furo[3,2-d]pyrimidine compounds |
12/11/2013 | CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof |
12/11/2013 | CN103435595A Acetylenic heteroaryl compounds |
12/11/2013 | CN103435594A 2-amino-quinazolines PLK1 (Polo-like kinase1) inhibitor and application thereof |
12/11/2013 | CN103435559A New erlotinib hydrochloride crystal form and preparation method thereof |
12/11/2013 | CN103435558A Synthetic method of quinazoline derivative |
12/11/2013 | CN103435557A 5-fluorocytosine preparation method |
12/11/2013 | CN103435556A Simple and quick method for synthesizing improved vitamin B1 intermediate 2-methyl-4-amino-5-aminomethylpyrimidine |
12/11/2013 | CN103435555A Preparation method of 4-chloro-5-methylpyrimidine |
12/11/2013 | CN102267952B Quinazoline compound and preparation method and application thereof |
12/11/2013 | CN101888999B Pyridylmethyl-sulfonamide compounds |
12/10/2013 | USRE44638 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
12/10/2013 | US8604194 Salts of O-desmethyl-venlafaxine |
12/10/2013 | US8604193 Processes for preparing HIV reverse transcriptase inhibitors |
12/10/2013 | US8604192 Cyclohexenyl nucleic acids analogs |
12/10/2013 | US8604082 Method to treat premature ejaculation in humans |
12/10/2013 | US8604055 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
12/10/2013 | US8604042 Bi-aryl meta-pyrimidine inhibitors of kinases |
12/10/2013 | US8604032 Chemical compounds, compositions and methods for kinase modulation |
12/10/2013 | CA2733659C Sulfoxime pesticidal compounds and methods related thereto |
12/10/2013 | CA2656825C Method of treatment and agents useful for same |
12/10/2013 | CA2599511C 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists |
12/05/2013 | WO2013181217A2 Novel compounds and compositions for treatment of breathing control disorders or diseases |
12/05/2013 | WO2013181135A1 Quinazoline derivatives, compositions, and uses related thereto |
12/05/2013 | WO2013180376A1 New electron transport material and organic electroluminescent device using the same |
12/05/2013 | WO2013179105A1 Improved process for preparation of rilpivirine and pharmaceutically acceptable salts thereof |
12/05/2013 | WO2013178816A1 Heterocycles capable of modulating t-cell responses, and methods of using same |
12/05/2013 | WO2013178591A1 Aminoquinazoline and pyridopyrimidine derivatives |
12/05/2013 | WO2013178576A1 Acid ceramidase inhibitors and their use as medicaments |
12/05/2013 | WO2013178545A1 Acid ceramidase inhibitors and their use as medicaments |
12/05/2013 | WO2013178362A1 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma] |
12/05/2013 | WO2013178020A1 Etravirine preparing method and intermediate thereof |
12/05/2013 | WO2013177713A1 Process for preparation of an antifolate agent |
12/05/2013 | WO2013153161A3 Polymorph of rilpivirine hydrochloride |
12/05/2013 | US20130324727 Anti-folate antimalarials with dual-binding modes and their preparation |
12/05/2013 | US20130324724 Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds |
12/05/2013 | US20130324566 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof |
12/05/2013 | US20130324546 Selective fak inhibitors |
12/05/2013 | US20130324532 Fak inhibitors |
12/05/2013 | US20130324524 2,4-pyrimidinediamine compounds and their uses |
12/05/2013 | US20130324516 Aminoquinazoline and pyridopyrimidine derivatives |
12/05/2013 | US20130324494 Novel pharmaceutical compounds |
12/05/2013 | US20130324412 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops |
12/05/2013 | CA2875012A1 Novel compounds and compositions for treatment of breathing control disorders or diseases |
12/05/2013 | CA2874938A1 Heterocycles capable of modulating t-cell responses, and methods of using same |
12/04/2013 | EP2669266A1 Improved Method for Manufacturing Dipeptidyl Peptidase-IV Inhibitor and Intermediate |
12/04/2013 | EP2668168A1 COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION |
12/04/2013 | EP2667716A1 Arylalkyl esters of 4-amino-6-(substituted phenyl)picolinates and 6-amino-2-(substituted phenyl)-4-pyrimidinecarboxylates and their use as herbicides |
12/04/2013 | EP2489350B1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
12/04/2013 | CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications |
12/04/2013 | CN103429576A Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof |
12/04/2013 | CN103429575A Fe(III) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias |
12/04/2013 | CN103429574A Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
12/04/2013 | CN103420925A Polymorphs of derivatives of 4-aniline quinazoline and manufacturing method and application thereof |
12/04/2013 | CN103420924A Preparation method of Erlotinib Hydrochloride crystal form A |
12/04/2013 | CN103420923A 4-aminoquinazolinehydroxamic acid compounds and applications thereof as antitumor medicaments |
12/04/2013 | CN103420922A Industrialized production method for erlotinib hydrochloride B type crystal |
12/04/2013 | CN103420921A Method for synthesizing optically-active 2,3-dihydro quinazolinone derivative by using chiral spiro phosphoric acid as catalyst |
12/04/2013 | CN103420920A Rilpivrine hydrochloride alcoholate polymorphs and preparation methods thereof |
12/04/2013 | CN103420919A Synthetic method for pyrimidine derivatives |
12/04/2013 | CN103420918A Simple and convenient preparation method of key intermediate (2-methyl-4-amino-5-amino methyl pyrimidine) for vitamin B1 |
12/04/2013 | CN103420811A Intermediate compound used for preparing Ambrisentan, preparation method thereof, and preparation of Ambrisentan |
12/04/2013 | CN103420749A Green synthesis method of thiourea derivative |
12/04/2013 | CN102516994B Fluorescence chemical sensors for mercury ion detection and preparation and application method |
12/04/2013 | CN101622231B 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
12/04/2013 | CN101466665B Compositions useful as inhibitors of voltage-gated sodium channels |
12/03/2013 | US8598365 Herbicides |
12/03/2013 | US8598364 Oligomer-protease inhibitor conjugates |
12/03/2013 | US8598346 Synthesis of cyclic amidines |
12/03/2013 | US8598344 CDKI pathway inhibitors and uses thereof |
12/03/2013 | US8598341 Process for etravirine intermediate and polymorphs of etravirine |
12/03/2013 | US8598182 Insecticidal pyrimidinyl aryl hyrdrazones |
12/03/2013 | US8598175 Heteroarylamide pyrimidone derivatives |
12/03/2013 | US8598171 Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders |
12/03/2013 | US8598148 Synthesis of tetracyclines and analogues thereof |
12/03/2013 | US8598085 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
12/03/2013 | CA2611312C Organic compounds |
12/03/2013 | CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
12/03/2013 | CA2530302C Novel aminobenzophenone compounds |